New study shows how the Crimean-Congo hemorrh

<p><strong>Researchers at Karolinska Institutet, in collaboration with JLP Health and others, have identified how the tick-borne Crimean-Congo haemorrhagic fever virus enters our cells. The results are published in <em>Nature Microbiology </em>and are an important step in the development of drugs against the deadly disease. </strong></p>

Related Keywords

United States ,Germany ,Spain ,Congo ,Sweden ,France ,Austria ,Vienna ,Wien ,Swedish ,Nazif Elaldi ,Ali Mirazimi ,Stephanie Devignot ,Volkerm Lauschke ,Ahmed Ibrahim ,Vanessam Monteil ,Maxj Kellner ,Georg Michlits ,Davidw Hawman ,Samir Abdurahman ,Mattia Mirandola ,Josephm Penninger ,Friedemann Weber ,Ioannis Pittarokoilis ,Karolinska Institutet ,Moritz Horn ,Cristiano Salata ,Heinz Feldmann ,Nuria Monserrat ,Binnur Bagci ,Hyesoo Kwon ,Sonia Youhanna ,Sebastianw Platzer ,Swedish Research Council ,Helmholtz Centre For Infection Research ,Method Of Research ,Department Of Laboratory Medicine ,National Institutes Of Health ,University Of Vienna ,Nature Microbiology ,Central Asia ,Middle East ,Laboratory Medicine ,Medical University ,Helmholtz Centre ,Infection Research ,National Institutes ,Crimean Congo Hemorrhagic Fever ,Matheus Dyczynski ,Sofia Appelberg ,Elizabeth Elder ,Teodor Aastrup ,